Vanguard Group Inc. Buys 71,539 Shares of Indivior PLC $INDV

Vanguard Group Inc. grew its position in Indivior PLC (NASDAQ:INDV) by 1.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 4,631,221 shares of the company’s stock after buying an additional 71,539 shares during the period. Vanguard Group Inc. owned approximately 3.36% of Indivior worth $43,765,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of INDV. XTX Topco Ltd lifted its position in Indivior by 123.9% during the first quarter. XTX Topco Ltd now owns 50,437 shares of the company’s stock valued at $481,000 after purchasing an additional 27,906 shares during the period. Y Intercept Hong Kong Ltd bought a new position in shares of Indivior during the 1st quarter valued at approximately $207,000. New York State Common Retirement Fund purchased a new stake in shares of Indivior in the first quarter worth $295,000. Cannon Global Investment Management LLC purchased a new stake in Indivior in the 1st quarter worth $95,000. Finally, Schaper Benz & Wise Investment Counsel Inc. WI purchased a new stake in shares of Indivior during the first quarter worth about $95,000. 60.33% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on INDV shares. HC Wainwright began coverage on shares of Indivior in a report on Wednesday, August 6th. They issued a “buy” rating and a $27.00 price target on the stock. Wall Street Zen upgraded Indivior from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 21st. Craig Hallum raised their price objective on shares of Indivior from $15.00 to $22.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. Finally, Jefferies Financial Group began coverage on shares of Indivior in a research note on Tuesday, July 22nd. They set a “buy” rating and a $20.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $19.60.

Indivior Trading Down 1.3%

INDV stock opened at $24.01 on Tuesday. Indivior PLC has a 52 week low of $7.33 and a 52 week high of $24.66. The firm has a 50 day moving average of $18.00 and a 200 day moving average of $13.16.

Indivior (NASDAQ:INDV) last issued its earnings results on Thursday, July 31st. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.25. Indivior had a negative return on equity of 86.28% and a net margin of 6.65%.The company had revenue of $302.00 million during the quarter, compared to analyst estimates of $239.43 million. Indivior has set its FY 2025 guidance at EPS. As a group, analysts predict that Indivior PLC will post 1.22 EPS for the current fiscal year.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.